Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion type Assertion NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_head.
- NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion description "[Treatment of CD33-transfected FA group F lymphoblastoid cells with 0.1 mg/mL His-M195FANCF conferred resistance to mitomycin C. No similar protection was noted in CD33(-) parental cells or CD33(+) FA cells belonging to groups A and C. These results demonstrate that antibody-directed, receptor-mediated protein transfer is a versatile method for the delivery of biologically active proteins into hematopoietic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_provenance.
- NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion evidence source_evidence_literature NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_provenance.
- NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion SIO_000772 11739191 NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_provenance.
- NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion wasDerivedFrom befree-20140225 NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_provenance.
- NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_assertion wasGeneratedBy ECO_0000203 NP758070.RASKqLw1n8mq6HNcA5gUVpFV3A7VDdVXh5VyUiCSdRn4w130_provenance.